Concepedia

David J. Augeri

DJ

Statistics

Publications

25

Citations

5.4K

H-Index

19

Active since

1988

Affiliations

Rutgers, The State University of New Jersey(Current)

Abbott Fund

Johnson University

Abbott (United Kingdom)

Bristol-Myers Squibb (United States)

David J. Augeri is an author at Rutgers, The State University of New Jersey specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1988–2024

25

Publications

25

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations

, , +14

Discovery and Preclinical Profile of Saxagliptin (BMS-477118):  A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text

, , +10

Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x <sub>L</sub> from NMR and Parallel Synthesis

Andrew M. Petros, Jürgen Dinges, David J. Augeri et al. · Journal of Medicinal Chemistry · 2005 · 293 citations

, , +14

NMR-Based Screening of Proteins Containing <sup>13</sup>C-Labeled Methyl Groups

Philip J. Hajduk, David J. Augeri, J. Mack et al. · Journal of the American Chemical Society · 2000 · 207 citations

, , +14

Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis

Philip J. Hajduk, Jürgen Dinges, Jeffrey M. Schkeryantz et al. · Journal of Medicinal Chemistry · 1999 · 119 citations · Full text

, , +16

1–5 of 25